Your session is about to expire
← Back to Search
Simple Versus Radical Hysterectomy for Stage I Cervical Cancer
N/A
Waitlist Available
Led By Charlotte C. Sun, DrPH
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
The primary objective of this study is to assess the preferences (values and utilities) of women for complications and recurrences associated with the surgical treatment of cervical cancer. A secondary objective of this study is to compare the preferences of women at high-risk for developing cervix cancer with the preferences of women who have already been diagnosed with cervix cancer.
Eligible Conditions
- Cervical Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Surgical Treatment PreferencesExperimental Treatment1 Intervention
Assessment of patient's feelings toward risks associated with surgical treatment of cervical cancer.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Interview
2019
N/A
~1100
Find a Location
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
3,071 Previous Clinical Trials
1,803,118 Total Patients Enrolled
Charlotte C. Sun, DrPHPrincipal InvestigatorM.D. Anderson Cancer Center